Evidence note: Eloralintide (LY3841136) is an investigational amylin receptor agonist developed by Eli Lilly and Company. It is not approved by any regulator. Nothing on this page is medical advice or a recommendation to use any substance.
Online communities discuss eloralintide often. This page applies the same evidence grading we use across the site: community reports sit near the bottom of the ladder.
Evidence ladder
- Peer-reviewed clinical findings
- Official trial registrations
- Sponsor announcements
- Recovered laboratory records
- Community anecdotes (this page)
Typical claims and how they grade
| Claim seen online | Grade | What would verify it |
|---|---|---|
| It causes strong appetite suppression | Plausible; consistent with trial reports | Published Phase 2 data |
| Nausea is mild | Unverified for any individual | Adverse-event tables in publications |
| Vendor material matches trial material | Unsupported | Independent identity and purity testing; still not equivalent to trial material |
| A specific personal dose works | Anecdote; not guidance | No substitute for clinical supervision |
We do not endorse or reproduce individual posts.
Related
What the trials studied ยท How to read a test report
Frequently asked questions
Is Reddit a reliable source for eloralintide?
No. Posts are anonymous, unverified and cannot confirm what substance was used, its dose or its purity. They can show what questions people ask, not what works.
What should I trust instead?
Registered trials, peer-reviewed publications and sponsor disclosures, graded by provenance.
Related reading: is it legal to buy eloralintide and where to buy eloralintide (research use only).